RecruitingNot ApplicableNCT07065721

Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults

CAPAZ-2D: Continuous Glucose Monitoring to Augment and Personalize Self-Management of Type 2 Diabetes in Hispanic/Latinx Young Adults

Sponsor

San Diego State University

Enrollment

40 participants

Start Date

Oct 2, 2025

Study Type

INTERVENTIONAL

Conditions

Type 2 Diabetes Mellitus (T2DM)

Summary

Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitators of CGM use, participants' changes in awareness of glucose patterns while using the CGM, and preferences for a CGM-based self-management intervention.

Eligibility

Min Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether using a wearable continuous glucose monitor (CGM) — a small sensor worn on the body that tracks blood sugar levels in real time throughout the day — can help young adults better manage their type 2 diabetes compared to standard care. The CGM connects to a smartphone app and shows blood sugar trends without finger-stick testing. **You may be eligible if...** - You are 18 to 45 years old - You were diagnosed with type 2 diabetes within the last 5 years - You have never used a wearable CGM device before - You own a smartphone compatible with the Dexcom CGM app and are willing to download and use it - You speak English or Spanish **You may NOT be eligible if...** - You have a serious mental illness such as psychosis or active suicidal thoughts - You are currently pregnant or less than 6 months postpartum Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEContinuous glucose monitor

Participants will wear a continuous glucose monitoring sensor for 30 days. They will also wear a FitBit wrist watch to be able to track their physical activity and they will complete weekly surveys to report diabetes self-management behaviors. After the 30 days, they will participate in a qualitative interview to respond to questions about their experiences.